Team:StanfordBrownSpelman/Amberless Hell Cell
From 2014.igem.org
(Difference between revisions)
(8 intermediate revisions not shown) | |||
Line 124: | Line 124: | ||
<div class="row"> | <div class="row"> | ||
<div class="small-8 small-centered columns"> | <div class="small-8 small-centered columns"> | ||
- | <h5><center>Results</h5> | + | <h5><center>Results Part 1 - Codon Security</h5> |
<h6> | <h6> | ||
We first tested the <b>Codon Security</b> hypothesis with the GFP test plasmid. We cloned the synthesized GFP+tRNA construct into pSB1C3. We initially tried to transform it into DH5-alpha cells, but effeciency was very low. Sequencing of the growing colonies showed interesting deletions or mutations in the tRNA portion of the construct, giving some evidence supporting our hypothesis that the tRNA was able to be expressed but toxic to the cells. We then BioBricked the GFP and tRNA portions separately. The GFP with 2 stop codons but no tRNA (GFP-2S) was stably transformed into DH5-alpha and amberless cells, and as expected, neither cell-type had fluorescent colonies. The tRNA biobrick could not be cloned in DH5-alpha cells; all colonies came back with mutations in the tRNA, further supporting the idea that non-amberless cells cannot tolerate the supP tRNA. We could only biobrick the tRNA in the Amberless chassis.<br><br> | We first tested the <b>Codon Security</b> hypothesis with the GFP test plasmid. We cloned the synthesized GFP+tRNA construct into pSB1C3. We initially tried to transform it into DH5-alpha cells, but effeciency was very low. Sequencing of the growing colonies showed interesting deletions or mutations in the tRNA portion of the construct, giving some evidence supporting our hypothesis that the tRNA was able to be expressed but toxic to the cells. We then BioBricked the GFP and tRNA portions separately. The GFP with 2 stop codons but no tRNA (GFP-2S) was stably transformed into DH5-alpha and amberless cells, and as expected, neither cell-type had fluorescent colonies. The tRNA biobrick could not be cloned in DH5-alpha cells; all colonies came back with mutations in the tRNA, further supporting the idea that non-amberless cells cannot tolerate the supP tRNA. We could only biobrick the tRNA in the Amberless chassis.<br><br> | ||
Line 161: | Line 161: | ||
</div></div> | </div></div> | ||
<div class="small-8 small-centered columns"><center><img src="https://static.igem.org/mediawiki/2014/0/01/SBS_AmberlessResults_Plates.png"><br> | <div class="small-8 small-centered columns"><center><img src="https://static.igem.org/mediawiki/2014/0/01/SBS_AmberlessResults_Plates.png"><br> | ||
- | <h6><b>Figure 6.</b> Plates after transforming (at Day 0) DH5-alpha and Amberless cells with aeBlue-3S+tRNA. At Day 1, after overnight incubation at 37C, there are no DH5-alpha colonies, but there are over 200 Amberless colonies. At Day 5, 4 days of room temperature incubation, Amberless colonies express the aeBlue protein and colonies appear in DH5-alpha plate, although possibly because of degradation of Chlor antibiotic. Side-by-side comparison of cell pellets shows that only Amberless express the blue protein | + | <h6><b>Figure 6.</b> Plates after transforming (at Day 0) DH5-alpha and Amberless cells with aeBlue-3S+tRNA. At Day 1, after overnight incubation at 37C, there are no DH5-alpha colonies, but there are over 200 Amberless colonies. At Day 5, 4 days of room temperature incubation, Amberless colonies express the aeBlue protein and colonies appear in DH5-alpha plate, although possibly because of degradation of Chlor antibiotic. Side-by-side comparison of cell pellets shows that only Amberless strongly express the blue protein.</h6> |
</div>. | </div>. | ||
<div class="row"> | <div class="row"> | ||
Line 168: | Line 168: | ||
<!-- ===== end figure ==== --> | <!-- ===== end figure ==== --> | ||
<h6> | <h6> | ||
- | + | As seen in Figure 6, we observed that the sequence-verified aeBlue-3S+tRNA construct could only be transformed into and expressed in Amberless cells. The kinetics of blue protein accumulation in the Amberless cells were relatively slow compared to GFP, with first visible signs at Day 2. We plan to determine the kinetics more thoroughly in an future experiment. Additionally, higher temperatures of incubation were less conducive to protein production; room temperature to 30C was the optimal temperature. The cells were removed from the each plate at Day 5 and lysed for Western blotting. | |
+ | </h6> | ||
+ | |||
+ | <!-- ===== Figure ===== --> | ||
+ | </div></div> | ||
+ | <div class="small-7 small-centered columns"><br><center><img src="https://static.igem.org/mediawiki/2014/e/e0/SBS_AmberlessWestern.png"><br> | ||
+ | <h6><b>Figure 7.</b> The aeBlue-3S construct has an N-terminal FLAG-tag that can be detected by Western blot using an anti-FLAG antibody. Lane A has twice the cell lysate concentration of lane B. The band at approximately 30kDa is near the expected molecular weight of the complete aeBlue product (28kDa), meaning that Amberless cells, but not DH5-alpha cells, express the complete protein. | ||
+ | </div> | ||
+ | <div class="row"> | ||
+ | <div id="subheader" class="small-8 small-centered columns"> | ||
+ | |||
+ | <!-- ===== end figure ==== --> | ||
+ | |||
+ | <h6> | ||
+ | Figure 7 shows that the Amberless cells only produce the full aeBlue-3S protein. Any truncated products would appear at 7, 13, and 20 kDa depending on the stop codon. DH5-alpha do not produce any protein, or a possible alternative is that truncated products degrade quickly in the cell and do not appear in the gel. These data strongly indicate that the supP tRNA enables protein expression through UAG stop codons only in Amberless cells and serve as a proof of concept for our Codon Security strategy. | ||
+ | </h6> | ||
+ | |||
+ | <h5><center>Results Part 2 - Amberless Hell Cell</h5> | ||
+ | <h6> | ||
+ | In parallel with demonstrating the Codon Security concept, we worked on applying it to radiation resistance genes to create the Amberless Hell Cell chassis. The goal of this part of the project was to confer resistances to Amberless Cells so that they could survive in harsh environments encountered in UAV or space applications. At the same time, we wanted to prove that applying Codon Security, we could ensure that using these "super-strains" of Amberless in the environment would not pose a risk of horizontal gene transfer into other bacteria. <br><br> | ||
+ | |||
+ | We first isolated 5 radiation resistance genes by PCR from <i>D. radiodurans</i> genomic DNA: <a href="http://parts.igem.org/Part:BBa_K1499200" target="_blank">uvsE</a> [3], <a href="http://parts.igem.org/Part:BBa_K1499201" target="_blank">uracil glycosylase 1</a>, <a href="http://parts.igem.org/Part:BBa_K1499202" target="_blank">uracil glycosylase 2</a> [4], <a href="http://partsregistry.org/Part:BBa_K847005" target="_blank">MntH</a>, and <a href="http://partsregistry.org/Part:BBa_K847002" target="_blank">DpsMP1</a>. Of these, the last two were previous Stanford-Brown 2012 biobricks that we re-isolated for sequence fidelity. The uvsE and MntH were chosen for initial testing. | ||
</h6> | </h6> | ||
Line 174: | Line 195: | ||
</div></div> | </div></div> | ||
<div class="small-7 small-centered columns"><br><center><img src="https://static.igem.org/mediawiki/2014/e/e4/SBS_AmberlessResults_rad1.png"><br> | <div class="small-7 small-centered columns"><br><center><img src="https://static.igem.org/mediawiki/2014/e/e4/SBS_AmberlessResults_rad1.png"><br> | ||
- | <h6><b>Figure | + | <h6><b>Figure 8.</b> Comparison of radiation resistance genes by measuring the fraction of colonies present after exposure to different amounts of UVC radiation. SOD was a resistance gene with unknown radiation resistance qualities. MntH Mut3 was a version of MntH with a UAG stop codon for leucine. Only uvsE-transformed cells showed an indication of radiation resistance. |
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
Line 182: | Line 203: | ||
<h6> | <h6> | ||
- | + | After determining that uvsE was a new gene that could confer increased radiation resistance to DH5-alpha cells, we repeated the experiment with three replicates of a DH5-alpha negative control and DH5-alpha transformed with uvsE. | |
</h6> | </h6> | ||
Line 188: | Line 209: | ||
</div></div> | </div></div> | ||
<div class="small-7 small-centered columns"><br><center><img src="https://static.igem.org/mediawiki/2014/0/03/SBSiGEM_HellCell2.png"><br> | <div class="small-7 small-centered columns"><br><center><img src="https://static.igem.org/mediawiki/2014/0/03/SBSiGEM_HellCell2.png"><br> | ||
- | <h6><b>Figure | + | <h6><b>Figure 9.</b> UvsE confers significant radiation resistance to DH5-alpha cells after exposure to UVC. Data were determined to be significant to p<.05 and p<.01 using a two-tailed Student's t-test. |
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
Line 196: | Line 217: | ||
<h6> | <h6> | ||
- | + | We determined that the <i>D. radiodurans</i> UV damage endonuclease uvsE gene can confer extra radiation resistance to <i>E. coli</i>. After confirming its efficacy, we used mutagenesis PCR to introduce stop codons at two different sites on the uvsE gene. Sequencing showed that our mutagenesis protocol for TTG(leucine)->TAG(stop) produces 70-95% of plasmids with the desired mutation. We are currently working on assembling this uvsE-stop codon gene with the supP tRNA to show that radiation resistance will only occur in Amberless cells when Codon Security is employed. | |
</h6> | </h6> | ||
Line 215: | Line 236: | ||
<h5><center>Conclusions</h5> | <h5><center>Conclusions</h5> | ||
<h6> | <h6> | ||
- | ● | + | ● We showed that Codon Security prevents DH5-alpha from expressing a construct containing stop codons. Despite having the supP tRNA in the construct, the cells do not survive transformation or fail to produce the protein of interest with mutated supP due to the toxicity of having a UAG-reading tRNA.<br><br> |
- | ● | + | ● We have created an orthogonal synthetic biology system such that genes only properly translate in the Amberless chassis.<br><br> |
- | ● | + | ● We isolated a radiation resistance gene from <i>D. radiodurans</i>, uvsE, and have for the first time shown its radiation resistance effects in <i>E. coli</i>. |
</h6> | </h6> | ||
Line 239: | Line 260: | ||
1. Lajoie, MJ <i>et al.</i> (2013) Genomically Recoded Organisms Impart New Biological Functions. <i>Science</i> 342: 357-60. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/24136966" target="_blank">24136966</a>.<br><br> | 1. Lajoie, MJ <i>et al.</i> (2013) Genomically Recoded Organisms Impart New Biological Functions. <i>Science</i> 342: 357-60. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/24136966" target="_blank">24136966</a>.<br><br> | ||
- | 2. Thorbjarnardóttir, S <i>et al.</i> (1985) Leucine tRNA family of Escherichia coli: nucleotide sequence of the supP(Am) suppressor gene. <i>J. Bacteriol.</i> 161: 219–22. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/2981802" target="_blank">2981802</a>.</a></ | + | 2. Thorbjarnardóttir, S <i>et al.</i> (1985) Leucine tRNA family of Escherichia coli: nucleotide sequence of the supP(Am) suppressor gene. <i>J. Bacteriol.</i> 161: 219–22. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/2981802" target="_blank">2981802</a>.<br><br> |
- | + | ||
+ | 3. Earl, AM <i>et al.</i> (2002) Genetic evidence that the uvsE gene product of <i>Deinococcus radiodurans</i> R1 is a UV damage endonuclease. <i>J. Bacteriol.</i> 184(4):1003-9. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/11807060" target="_blank">11807060</a>.<br><br> | ||
+ | |||
+ | 4. Sandigursky, M <i>et al.</i> (2004) Multiple uracil-DNA glycosylase activities in <i>Deinococcus radiodurans</i>. <i>DNA Repair (Amst)</i> 3(2):163-9. PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/14706350" target="_blank">14706350</a>. | ||
+ | |||
+ | </h6></div> | ||
+ | |||
</div> | </div> | ||
</div> | </div> |
Latest revision as of 03:34, 18 October 2014
Amberless Hell Cell
For an application of synthetic biology where live, genetically-modified cells will come in direct contact with the environment, such as biological sensors on a UAV, two concerns must be addressed. First, the cells need to be resistant to widely-varying conditions that may be present in the environment. Second, in order to address ethical concerns about releasing genetically-modified organisms, it is desirable to reduce horizontal gene transfer from the engineered cells into cells naturally present in the environment. In order to solve both of these issues, and therefore to create an ideal chassis for synthetic biology in environmental applications, we will combine two research goals:
1. The "Hell Cell" project by the 2012 Stanford-Brown iGEM team isolated genes from extremophile bacterial species and inserted them into Escherichia coli, in order to create bacteria that are resistant to extremes in pH, temperature, and moisture. We sought to further characterize, improve, and search for new resistance genes that would help our chassis survive in earth and space applications.
2. The Church Lab at Harvard Medical School in 2013 created a strain of E. coli (C321.ΔA) in which all 321 instances of the UAG ("Amber") stop codon in the E. coli genome had been replaced with the UAA stop codon [1]. Release factor 1, which terminates translation at UAG, was also removed. With this system, the Church group incorporated artificial amino acids with a tRNA that recognizes UAG as its codon.
1. The "Hell Cell" project by the 2012 Stanford-Brown iGEM team isolated genes from extremophile bacterial species and inserted them into Escherichia coli, in order to create bacteria that are resistant to extremes in pH, temperature, and moisture. We sought to further characterize, improve, and search for new resistance genes that would help our chassis survive in earth and space applications.
2. The Church Lab at Harvard Medical School in 2013 created a strain of E. coli (C321.ΔA) in which all 321 instances of the UAG ("Amber") stop codon in the E. coli genome had been replaced with the UAA stop codon [1]. Release factor 1, which terminates translation at UAG, was also removed. With this system, the Church group incorporated artificial amino acids with a tRNA that recognizes UAG as its codon.